616
Views
0
CrossRef citations to date
0
Altmetric
Research Article

EGCG/Gelatin-Doxorubicin Gold Nanoparticles Enhance Therapeutic efficacy of Doxorubicin for Prostate Cancer Treatment

, , , &
Pages 9-30 | Received 15 Jun 2015, Accepted 30 Sep 2015, Published online: 11 Dec 2015

References

  • Cai LQ , XuGF , ShiCY , GuoDD , WangX , LuoJT . Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: a synergistic combination nanotherapy for ovarian cancer treatment . Biomaterials37 , 456 – 468 ( 2015 ).
  • Wang LM , LinXY , WangJet al. Novel insights into combating cancer chemotherapy resistance using a plasmonic nanocarrier: enhancing drug sensitiveness and accumulation simultaneously with localized mild photothermal stimulus of femtosecond pulsed laser . Adv. Funct. Mater.24 , 4229 – 4239 ( 2014 ).
  • Nguyen T , TekronyA , YaehneK , CrambDT . Designing a better theranostic nanocarrier for cancer applications . Nanomedicine9 , 2371 – 2386 ( 2014 ).
  • Chen X , SoeriyadiAH , LuXet al. Dual bioresponsive mesoporous silica nanocarrier as an “and” logic gate for targeted drug delivery cancer cells . Adv. Funct. Mater.24 , 6999 – 7006 ( 2014 ).
  • Van de Broek B , DevoogdtN , D’HollanderAet al. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment . ACS Nano8 , 4205 – 4220 ( 2014 ).
  • De Jong WH , HagensWI , KrystekPet al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration . Biomaterials29 , 1912 – 1919 ( 2008 ).
  • Marchesano V , HernandezY , SalvenmoserWet al. Imaging inward and outward trafficking of gold nanoparticles in whole animals . ACS Nano7 , 2431 – 2442 ( 2013 ).
  • Nicol JR , DixonD , CoulterJA . Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics . Nanomedicine10 , 1315 – 1326 ( 2015 ).
  • Li WW , ChenXY . Gold nanoparticles for photoacoustic imaging . Nanomedicine10 , 299 – 320 ( 2015 ).
  • Chen WH , XuXD , JiaHZet al. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo . Biomaterials34 , 8798 – 8807 ( 2013 ).
  • Barenholz Y . Doxil® – the first FDA-approved nano-drug: lessons learned . J. Control. Release160 , 117 – 134 ( 2012 ).
  • Tang S , YinQ , ZhangZWet al. Co-delivery of doxorubicin and RNA using pH-sensitive poly (beta-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer . Biomaterials35 , 6047 – 6059 ( 2014 ).
  • Batrakova EV . Overcoming multidrug resistance using silica nanoparticles PEG-b-PLA polymeric micelles loaded with doxorubicin . Nanomedicine6 , 1492 – 1493 ( 2011 ).
  • Wang F , WangYC , DouSet al. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells . ACS Nano5 , 3679 – 3692 ( 2011 ).
  • Meng H , XueM , XiaTet al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model . ACS Nano5 , 4131 – 4144 ( 2011 ).
  • Yang E , QianWP , CaoZHet al. Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery . Theranostics5 , 43 – 61 ( 2015 ).
  • Yu PC , YuHJ , GuoCYet al. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles . Acta Biomater.14 , 115 – 124 ( 2015 ).
  • Khan N , BharaliDJ , AdhamiVMet al. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model . Carcinogenesis35 , 415 – 423 ( 2014 ).
  • Rocha S , GeneralovR , PereiraMDet al. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention . Nanomedicine6 , 79 – 87 ( 2011 ).
  • Harper CE , PatelBB , WangJ , EltoumIA , LamartiniereCA . Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action . Prostate67 , 1576 – 1589 ( 2007 ).
  • Shukla R , ChandaN , ZambreAet al. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer . Proc. Natl Acad. Sci. USA109 , 12426 – 12431 ( 2012 ).
  • Hsieh DS , WangH , TanSWet al. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles . Biomaterials32 , 7633 – 7640 ( 2011 ).
  • Kumazoe M , SugiharaK , TsukamotoSet al. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis . J. Clin. Invest.123 , 787 – 799 ( 2013 ).
  • Fujimura Y , SumidaM , SugiharaKet al. Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor . PLoS ONE7 , e37942 ( 2012 ).
  • Chung JE , TanS , GaoSJet al. Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy . Nat. Nanotechnol.9 , 907 – 912 ( 2014 ).
  • Wong C , StylianopoulosT , CuiJAet al. Multistage nanoparticle delivery system for deep penetration into tumor tissue . Proc. Natl Acad. Sci. USA108 , 2426 – 2431 ( 2011 ).
  • Xu JH , GaoFP , LiuXFet al. Supramolecular gelatin nanoparticles as matrix metalloproteinase responsive cancer cell imaging probes . Chem. Commun.49 , 4462 – 4464 ( 2013 ).
  • Shutava TG , BalkundiSS , VangalaPet al. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols . ACS Nano3 , 1877 – 1885 ( 2009 ).
  • Neupane MP , LeeSJ , ParkISet al. Synthesis of gelatin-capped gold nanoparticles with variable gelatin concentration . J. Nanopart. Res.13 , 491 – 498 ( 2011 ).
  • Zhu H , DuML , ZouMLet al. Facile and green synthesis of well-dispersed Au nanoparticles in PAN nanofibers by tea polyphenols . J. Mater. Chem.22 , 9301 – 9307 ( 2012 ).
  • Wu H , HuangX , GaoMM , LiaoXP , ShiB . Polyphenol-grafted collagen fiber as reductant and stabilizer for one-step synthesis of size-controlled gold nanoparticles and their catalytic application to 4-nitrophenol reduction . Green Chem.13 , 651 – 658 ( 2011 ).
  • Usha R , RamasamiT . Structure and conformation of intramolecularly cross-linked collagen . Colloids Surf B Biointerfaces41 , 21 – 24 ( 2005 ).
  • Jin WP , XuW , GeHH , LiY , LiB . Polyphenol-gelatin nanoparticles as reductant and stabilizer for one-step synthesis of gold nanoparticles and their interfacial behavior . RSC Adv.5 , 26496 – 26503 ( 2015 ).
  • Hong Y , KuM , HeoDet al. Molecular recognition of proteolytic activity in metastatic cancer cells using fluorogenic gold nanoprobes . Biosens. Bioelectron.57 , 171 – 178 ( 2014 ).
  • Barazzouk S , KamatPV , HotchandaniS . Photoinduced electron transfer between chlorophyll a and gold nanoparticles . J. Phys. Chem. B109 , 716 – 723 ( 2005 ).
  • Chen WH , LuoGF , LeiQet al. MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery . Chem. Commun.51 , 465 – 468 ( 2015 ).
  • Chen WH , XuXD , JiaHZet al. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo . Biomaterials34 , 8798 – 8807 ( 2013 ).
  • van Rijt SH , BolukbasDA , ArgyoCet al. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors . ACS Nano9 , 2377 – 2389 ( 2015 ).
  • Dorresteijn R , BilleckeN , SchwendyMet al. Polylactide-block-polypeptide-block-polylactide copolymer nanoparticles with tunable cleavage and controlled drug release . Adv. Funct. Mater.24 , 4026 – 4033 ( 2014 ).
  • Trudel D , FradetY , MeyerF , HarelF , TetuB . Significance of MMP-2 expression in prostate cancer: an immunohistochemical study . Cancer Res.63 , 8511 – 8515 ( 2003 ).
  • Stearns ME , AmatangeloMD , VarmaD , SellC , GoodyearSM . Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies inhibition of metastatic tumor growth in severe combined immunodeficiency mice . Am. J. Pathol.177 , 3169 – 3179 ( 2010 ).
  • Kelly MM , HoelBD , Voelkel-JohnsonC . Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression . Cancer Biol. Ther.5 , 520 – 527 ( 2002 ).
  • Albrecht DS , ClubbsEA , FerruzziM , BomserJA . Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation . Chem. Biol. Interact.171 , 89 – 95 ( 2008 ).
  • Gupta S , HastakK , AfaqF , AhmadN , MukhtarH . Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis . Oncogene23 , 2507 – 2522 ( 2004 ).
  • Shabana SM , SiddiquiIA , KhanNet al. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human prostate carcinoma cells . J. Pharmaceut. Pharmacol.2 , 1 – 8 ( 2014 ).
  • Lu YC , LuoPC , HuangCWet al. Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interaction . Nanoscale6 , 10297 – 10306 ( 2014 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.